References
- Åsbrink E, Olsson I. Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients. Acta Derm Venereol (Stockh) 1985; 65: 43–52.
- Åsbrink E. Dermatological variations of Lyme borreliosis. In: VIII International Conference on Lyme borreliosis and other emerging tick-borne diseases, Munich, 1999; 79: 24.
- Zajkowska J, Hermanowska-Szpakowicz T, Coyle P, Ostrowska J, Pancewicz B, Kondrusik M. Comparative study of early Lyme disease erythema migrans in New York State and northeastern Poland. Med Sci Monit 2002; 8: CR37–43.
- Wahlberg P, Granlund H, Nyman D, Panelius J, Seppälä I. Late Lyme borreliosis: epidemiology, diagnosis and clinical features. Ann Med 1993; 25: 349–52.
- Carlsson S-A, Granlund H, Nyman D, Wahlberg P. IgG seroprevalence of Lyme borreliosis in the population of the Åland Islands (Finland). Scand J Infect Dis 1998; 30: 501–3.
- Stanek G, O’Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granström M, et al. European Union concerted action on risk assessment in Lyme borreliosis; clinical case definitions for Lyme borreliosis, Wien Klin Wochenschr 1996; 108/23: 741–747.
- Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984; 57: 521–5.
- Marconi CT, Garon CF. Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis. J Clin Microbiol 1992; 30: 2830–4.
- Oksi J, Marttila H, Soini H, Aho H, Uksila J, Viljanen MK. Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans. APMIS 2001; 109: 581–8.
- Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parent DL, et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 2002; 136: 421–8.
- Strle F, Nadelman RB, Cimperman J, Noweakowski J, Picken RN, Schwartz I, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 1999; 130: 32–6.
- Logar M, Ruzic-Savljic E, Strle F, Maraspin V, Lotric-Furlan S, Cimperman J, Jurca T. Comparison of clinical and epidemiological features of erythema migrans caused by Borrelia afzelii and Borrelia garinii. In: IX International Conference on Lyme borreliosis and other tick-borne diseases, New York, 18–22 August 2002; Abstr O32.